The product names are fine and they are trying to become a leader in otc, men and women's healthcare products, so it takes time...we will have a new investor from the conference...even if the shares get fully diluted, after some continued success, they could always do a stock buy back, or perhaps get bought out. Innv doesn't have control of the fda anda fluticare timeline...Innv hasn't grown perfectly, but it is growing...